摘要
本文应用放射免疫沉淀法对94例经病理证实的消化系统恶性肿瘤(包括食管癌30例、胃癌47例、结肠直肠癌5例、原发性肝癌7例、胰腺癌2例、胆囊癌3例)作Ald-A测定。另有31例健康者作对照组,正常人血清Ald-A在0～18U/dl之间,均值为9.26±5.0U/dl(X±SD)。食管癌、胃癌、结肠直肠癌、胰腺癌和胆囊癌的Ald-A均值分别为10.23±9.1U/dl、9.94±9.2U/dl、12±8.21U/dl、9.5U/dl和4.83±2.84U/dl。与正常对照组比较无明显差异(P>0.05)。但原发性肝癌患者的血清Ald-A值明显增高,均值为30.03±23.54U/dl(P<0.001)。本文研究结果提示,用放免法测定Ald-A有助于肝癌病人的诊断。
Serum aldolase A level was measured by immunoprecipitative assay in 94 patients with various digestive malignancies (esophagus 30, stomach 47, colon 5, liver 7, pancreas 2, gall-bladder 3) and in 31 healthy individuals as control. The results show- ed that there was no significant difference (P>0.05) between studied patients and normal individuals except in patients with hepatoma. The mean value of ALD-A in hepatoma patients was 30.03±23.54 u/dl, much higher than other subjects inves- tigated.
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
1989年第4期195-197,共3页
Chinese Journal of Clinical Oncology
关键词
肝癌
消化系肿瘤
醛缩酶
Serum aldolase A
Liver carcinoma
Digestive system
Immunoprecipitative assay
